Polypharmacy/Related Articles: Difference between revisions
Jump to navigation
Jump to search
imported>Daniel Mietchen m (Robot: Starting Related Articles subpage. Please check and brush. For context, see here.) |
No edit summary |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
{{subpages}} | <noinclude>{{subpages}}</noinclude> | ||
==Parent topics== | ==Parent topics== | ||
Line 23: | Line 23: | ||
{{r|Systematic review}} | {{r|Systematic review}} | ||
{{Bot-created_related_article_subpage}} | |||
<!-- Remove the section above after copying links to the other sections. --> | <!-- Remove the section above after copying links to the other sections. --> | ||
==Articles related by keyphrases (Bot populated)== | |||
{{r|Selective serotonin uptake inhibitor}} | |||
{{r|Sibutramine}} | |||
{{r|Biotechnology}} | |||
{{r|Medically unexplained physical symptoms}} |
Latest revision as of 16:01, 5 October 2024
- See also changes related to Polypharmacy, or pages that link to Polypharmacy or to this page or whose text contains "Polypharmacy".
Parent topics
Subtopics
Bot-suggested topics
Auto-populated based on Special:WhatLinksHere/Polypharmacy. Needs checking by a human.
- Aspirin [r]: Common analgesic used for treating mild to moderate pain; protective against blood clots and heart disease when administered indefinitely in low doses [e]
- Dementia [r]: Progressive decline in two or more cognitive domains that is severe enough to interfere with the performance of everyday activities. [e]
- Digital object identifier [r]: Unique label for a computer readable object that can be found on the internet, usually used in academic journals. [e]
- Drug toxicity [r]: Manifestations of the adverse effects of drugs administered therapeutically or in the course of diagnostic techniques. [e]
- Geriatrics [r]: "the branch of medicine concerned with the physiological and pathological aspects of the aged, including the clinical problems of senescence and senility."(National Library of Medicine) [e]
- Medication [r]: A licensed drug taken to cure or reduce symptoms of an illness or medical condition. [e]
- Patient compliance [r]: Voluntary cooperation of the patient in following a prescribed regimen. [e]
- Systematic review [r]: Literature review focused on a single question that tries to identify, appraise, select and synthesize all high quality research evidence relevant to that question. [e]
- Selective serotonin uptake inhibitor [r]: The first class of second-generation antidepressants, with generally improved side effect profiles over tricyclic antidepressants and monoamine oxidase inhibitors [e]
- Sibutramine [r]: Centrally-acting serotonin-norepinephrine reuptake inhibitor structurally related to amphetamines used to help obese and overweight patients lose weight, originally used in the treatment of depression. [e]
- Biotechnology [r]: The application of biological principles in industrial production [e]
- Medically unexplained physical symptoms [r]: Symptoms for which the treating physician, other healthcare providers, and research scientists have found no medical cause. [e]